Swarnalatha Bheemreddy

Internal Medicine physician in Wilmington, Delaware — also lists obesity medicine in the CMS registry.

Practice Details

Address
701 N Clayton St Ste 533A
Wilmington, DE 19805
Geocoded location: 39.7496, -75.5667
Taxonomy
Internal Medicine
Credential
M.D
NPPES Enumeration
Listed with NPPES since 2008
Sole Proprietor
No
Provider Gender (NPPES)
Female
Also Listed As
Swarna Bheemreddy
NPPES Record Updated
May 2021

Specialty taxonomies on file (3)

  • Internal Medicine
  • Bariatric Surgery
    Surgery
  • Internal Medicine
    Internal Medicine, Cardiovascular Disease
    Primary

All specialty taxonomies this NPI reports in the CMS National Provider registry. A taxonomy on file reflects a self-reported designation, not confirmation of current services.

About This Clinician

Swarnalatha Bheemreddy is an Internal Medicine physician in Wilmington whose NPPES record also lists an obesity-medicine or bariatric-medicine taxonomy as a secondary specialty. Primary-care and family-medicine clinicians who carry this secondary designation are among those most likely to actively manage GLP-1 prescribing, though this registry entry does not confirm current prescribing practices — call ahead to confirm.

Locally, this is 1 of 185 Internal Medicine practices in Wilmington carrying this exact taxonomy in our directory.

What to expect at an Internal Medicine visit

Internal-medicine practices manage adult and often complex chronic conditions. A GLP-1-related visit commonly involves:

  • A review of chronic conditions, medications, and cardiovascular/metabolic risk.
  • Baseline labs (A1c, metabolic panel, lipids) to guide treatment.
  • A discussion of GLP-1 options for diabetes and/or weight management.
  • A plan for follow-up monitoring and dose adjustment.

This is general guidance for internal medicine practices, not a description of Swarnalatha Bheemreddy's specific protocol, services, or pricing. Confirm what a visit involves directly with the practice — 302-421-4828.

GLP-1 access in Wilmington, Delaware

Adult obesity rate
33.9%
#17 of 50 states (CDC BRFSS)
Avg. compounded semaglutide
$215/mo
Typical Delaware telehealth cash price
Medicaid GLP-1 coverage
Diabetes only
Delaware Medicaid, obesity indication

About 33.9% of Delaware adults have obesity (BMI 30+), ranking the state #17 of 50 (CDC BRFSS). Our directory currently lists 34 GLP-1-relevant clinics in Wilmington. If a cash-pay route makes more sense, compounded semaglutide through Delaware telehealth averages about $215/mo — well below brand-name Wegovy or Zepbound.

Explore more Delaware options on the best Delaware GLP-1 providers page, browse every Wilmington listing in the Wilmington clinic directory, or read the Delaware Medicaid GLP-1 coverage & prior-authorization guide.

Related Practices in Wilmington

Other Wilmington listings in the same directory tier:

Telehealth Alternative

Prefer not to visit in person? Licensed GLP-1 telehealth providers ship compounded semaglutide or tirzepatide directly to Delaware addresses, often faster and at lower cash cost than an in-person visit and brand-name prescription. Featured Delaware telehealth partners:

Featured Partners · Wilmington

Featured GLP-1 providers serving Wilmington

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

  1. Top pick

    Compounded from

    $249.99/mo

    Save $1,099.01/mo vs Wegovy
    Get started →
  2. Compounded from

    $99/mo

    Save $1,250/mo vs Wegovy
    Get started →
  3. Compounded from

    $199/mo

    Save $1,150/mo vs Wegovy
    Get started →
  4. Compounded from

    $147/mo

    Save $1,202/mo vs Wegovy
    Get started →
  5. 8.2

    Compounded from

    $149/mo

    Save $937/mo vs Zepbound
    Get started →
  6. Compounded from

    $249/mo

    Save $1,100/mo vs Wegovy
    Get started →

See more Wilmington options on the Wilmington clinic directory, our Wilmington GLP-1 telehealth page, or compare the best semaglutide providers nationwide.

Learn more about the medications most commonly prescribed by Wilmington obesity-medicine and endocrinology practices: Semaglutide and Tirzepatide.

Frequently Asked Questions

The CMS National Provider registry lists Swarnalatha Bheemreddy's specialty taxonomy but not the specific medications it prescribes or its current service menu. Swarnalatha Bheemreddy is listed under Internal Medicine, a field where GLP-1 medications such as semaglutide (Wegovy, Ozempic) or tirzepatide (Zepbound, Mounjaro) are commonly prescribed — but whether this practice currently offers them isn't recorded in the registry. Call the practice at 302-421-4828 to confirm before booking.
According to its CMS National Provider registry (NPPES) record, Swarnalatha Bheemreddy's primary specialty on file is Internal Medicine, with obesity medicine listed as a secondary taxonomy. Generalist clinicians who carry that secondary designation are among those who commonly manage GLP-1 prescribing, though the registry does not confirm current services.
Swarnalatha Bheemreddy is located at 701 N Clayton St Ste 533A, Wilmington, DE 19805. The phone number listed in the registry is 302-421-4828. Its full record is public in the CMS National Provider registry under NPI 1700038882.
New-patient status isn't recorded in the CMS National Provider registry, so we can't confirm whether Swarnalatha Bheemreddy is currently accepting new patients. Call the practice at 302-421-4828 to confirm availability, cash-pay pricing, and whether the services you need are offered — this listing reflects the NPPES taxonomy on file and is not an endorsement.